Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus
NCT: NCT06236256 · COMPLETED
Brief Summary
The trial is a randomized controlled, parallel group design study. Patients will be followed up during approximatively 12 months. Patients will be randomized to either the MDI/CSII group which will continue their treatment as per routine procedures and the advanced Hybrid Closed Loop system (AHCL) group which will be connected to the Minimed 780G system. . At the end of the 12 month study period, we will evaluate whether the AHCL system improved glucose indices in older individuals with Type 1 diabetes mellitus (T1DM) and assess whether the ACHL treatment improved physical capacity, frailty \& sarcopenia indices as well as quality of life and cognitive functions.
Frequently Asked Questions
What is Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus?
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus is a clinical trial registered under NCT06236256. Current status: COMPLETED.
What is the status of NCT06236256?
The current status of NCT06236256 (Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus) is: COMPLETED.
When did Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus start?
Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus started on 2024-01-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.